BusinessAXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to MarinolBy Nasdaq OMXMar 28, 2017, 1:01 PM UTC
BusinessEarth Science Tech, Enters Multi-Billion Dollar Sports Supplement Industry via Joint Venture with Nutrition Specialties and ForzagenBy Nasdaq OMXJan 31, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio CastilloBy Nasdaq OMXJan 25, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Signs Marketing & Media Agreement with Pearls of Health and Appoints Gabriel Aviles as Chief Sales Officer (CSO).By Nasdaq OMXJan 9, 2017, 12:45 PM UTC
BusinessEarth Science Tech Engages RedChip to Lead Investor Relations EffortsBy Nasdaq OMXDec 28, 2016, 9:05 PM UTC
BusinessEarth Science Tech Announces the Development of 3 New Advanced Formulated Cannabis CBD Nutraceuticals and 2 Cannabis CBD-Based Pharmaceutical Drugs under its Cannabis CBD Patent, IP and TechnologyBy Nasdaq OMXDec 20, 2016, 12:45 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
